TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment (METILDA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01995344 |
|
Recruitment Status :
Terminated
(Withdrawal of funding)
First Posted : November 26, 2013
Last Update Posted : April 20, 2023
|
Sponsor:
The Christie NHS Foundation Trust
Collaborator:
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
Christiesponsoredresearch, The Christie NHS Foundation Trust
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | July 24, 2015 |
| Actual Study Completion Date : | July 24, 2015 |